ARTICLE
30 March 2020

Canadian Intellectual Property Office Extends Deadlines In View Of COVID-19 Outbreak

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
In view of the COVID-19 outbreak, the Canadian Intellectual Property Office (CIPO) has announced that patent, trademark,...
Canada Coronavirus (COVID-19)

In view of the COVID-19 outbreak, the Canadian Intellectual Property Office (CIPO) has announced that patent, trademark, and industrial design deadlines that fall due between March 16, 2020 and March 31, 2020 will be extended until April 1, 2020. 

Smart & Biggar will continue to meet original CIPO deadlines upon receipt of timely instructions from our clients.

CIPO may decide to extend deadlines further, depending how circumstances evolve. Further details may be found on the CIPO website here.

Please contact your relationship partner for further guidance.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More